Stockreport

Cognition Therapeutics Reports Year End 2023 Financial Results and Provides Business Update

Cognition Therapeutics, Inc.  (CGTX) 
PDF - Topline Results from SHINE Study in Mild-to-Moderate Alzheimer’s Expected mid-2024 -- On Track to Report Topline Results from SHIMMER Study in Mild-to-Moderate DLB in [Read more]